Argireline vs Palmitoyl Tetrapeptide-7

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Argireline

Argireline (Acetyl Hexapeptide-3) is a widely-used cosmetic peptide that reduces wrinkle depth by inhibiting neurotransmitter release. One of the first 'Botox-like' peptides developed for topical use.

Full details →

Palmitoyl Tetrapeptide-7

Palmitoyl Tetrapeptide-7 is an anti-inflammatory peptide that reduces IL-6 secretion. Combined with Palmitoyl Tripeptide-1, it forms Matrixyl 3000, addressing both collagen production and inflammation.

Full details →

Side-by-Side Comparison

Aspect	Argireline	Palmitoyl Tetrapeptide-7
Dose Range	500 mcg–1 mg	500 mcg–2 mg
Frequency	2x daily	2x daily
Cycle Length	4–8 weeks	4–12 weeks
Route	topical	topical
Mechanism	Inhibits the formation of the SNARE complex required for neurotransmitter release, reducing the intensity of muscle contractions that cause expression lines.	Suppresses interleukin-6 (IL-6) production, reducing inflammation that contributes to skin aging. The anti-inflammatory effect complements collagen-stimulating peptides.
Typical Dosage	Topical: 5-10% concentration in serums, applied twice daily. Higher concentrations used in professional treatments.	Topical: Usually combined with Palmitoyl Tripeptide-1 at similar concentrations (2-4%) in the Matrixyl 3000 complex.
Administration	Topical application to clean skin. Most effective on expression lines (forehead, crow's feet). Consistent use required for visible results.	Topical application with other anti-aging actives. The palmitoyl group enhances delivery into the skin.
Side Effects	Generally very well-tolerated. Occasional mild irritation or dryness. No systemic absorption at cosmetic doses.	Excellent tolerability profile. Anti-inflammatory properties may actually soothe sensitive skin.
Best For	Anti-Aging & Longevity Skin Health & Aesthetics	Skin Health & Aesthetics